Gain Therapeutics Inc (GANX)

NASDAQ
7.490
+0.070(+0.94%)
  • Volume:
    976
  • Bid/Ask:
    7.450/7.650
  • Day's Range:
    7.430 - 7.490
  • Type:Equity
  • Market:United States
  • ISIN:US36269B1052
  • CUSIP:00036269B105

GANX Overview

Prev. Close
7.42
Day's Range
7.43-7.49
Revenue
100K
Open
7.43
52 wk Range
7.35-17.93
EPS
-
Volume
976
Market Cap
92.16M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
135,092
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
11,876,460
Next Earnings Date
Dec 01, 2021
What is your sentiment on Gain Therapeutics Inc?
or
Vote to see community's results!

Gain Therapeutics Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellNeutral

Gain Therapeutics Inc Company Profile

Gain Therapeutics Inc Company Profile

Sector
Services
Employees
16

Gain Therapeutics, Inc., a development stage biotechnology company, develops various therapeutics to treat diseases caused by protein misfolding. It focuses on lysosomal storage disorders, such as rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover novel allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites and restore protein folding treating the underlying disease. It is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson’s, Krabbe, and Mucopolysaccharidosis type 1 diseases. The company was founded in 2017 and is based in Bethesda, Maryland.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.